Pharmaceutical companies face patent cliff

Patents are worth a lot of money to the pharmaceutical industry. According to recent reports, the expiration of a series of pharmaceutical patents over the next five years is estimated to cost the top 500 companies $148 billion.

The patent cliff follows a boom period about 20 years ago in the development of new drugs. Pharmaceutical companies may overcome the patent cliff by creating innovative drugs and protecting them with patents.